Acute kidney injury in liver cirrhosis: Combining microbiome and metabolome in the search for biomarkers
Zeitschrift für Gastroenterologie · 01.05.2024 · 62 (05) · e505-e506
DOI: 10.1055/s-0044-1786949 ↗Kurz gefasst
Fachartikel in der Zeitschrift Zeitschrift für Gastroenterologie, erschienen am 01.05.2024. Verfasst von S. Fürst und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Acute kidney injury (AKI) is a common and serious complication in patients with liver cirrhosis. Diagnosis and staging predominantly rely on serum creatinine levels, which are influenced by patient muscle mass, introducing potential confounders such as sex and sarcopenia. New biomarker for early detection of AKI are therefore needed. Materials and methods: This retrospective analysis involved 14 cirrhotic patients with AKI, 11 cirrhotic controls, 20 non-cirrhotic controls and 14 sarcopenic non-cirrhotic controls, all matched for age and sex. AKI was defined as an increase in creatinine of>0.3mg/dl or>50% of the initial value. 16S rRNA gene sequencing was conducted on stool samples, alongside serum metabolomic analysis using Biocrates-MxP Quant 500 Kit and M21 UHPLC-HRMS QExactive. Results from both microbiome and metabolome analysis were further combined via multiomics factor analysis (MOFA) to identify influencing factors.
Results
Analysis revealed a higher abundance of potential pathogens in the stool of AKI patients with a decrease in gut commensals. We found indications for overgrowth and a shift towards “oralization”, which means that oral bacteria colonize the intestine. Serum metabolome distinguished between cirrhotic and non-cirrhotic individuals but less successfully between AKI and non-AKI cases in cirrhosis. MOFA revealed metabolome-dominated factors explaining more variance than microbiome-informed factors, showing more pronounced differences between AKI and non-AKI. Odd-chain fatty acids (OCFA) seem to be relevant metabolomic factors as multiple OCFA were found to be higher in AKI patients.
Conclusions
AKI in cirrhosis is associated with specific changes in the microbiome and metabolome, beyond the cirrhosis associated dysbiosis. Combining data pools yielded better results than separate analyses, with metabolome data better suited for discerning AKI presence in cirrhosis. This pilot study provides encouraging results, suggesting further research may uncover a biomarker panel for AKI in cirrhosis. Attention should be focused on OCFA, whose role is yet unclear. Publication History Article published online: 05 June 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
Zitieren
APA
Fürst, S., Schwarzl, J., Woltsche, J., Gulden, L., Zügner, E., Magnes, C., Horvath, A., & Stadlbauer-Köllner, V. (2024). Acute kidney injury in liver cirrhosis: Combining microbiome and metabolome in the search for biomarkers. Zeitschrift für Gastroenterologie, 62(05), e505-e506. https://doi.org/10.1055/s-0044-1786949
Vancouver
Fürst S, Schwarzl J, Woltsche J, Gulden L, Zügner E, Magnes C, et al. Acute kidney injury in liver cirrhosis: Combining microbiome and metabolome in the search for biomarkers. Zeitschrift für Gastroenterologie. 2024;62(05):e505-e506. doi:10.1055/s-0044-1786949
BibTeX
@article{Frst2024,
author = {Fürst, S. and Schwarzl, J. and Woltsche, J. and Gulden, L. and Zügner, E. and Magnes, C. and Horvath, A. and Stadlbauer-Köllner, V.},
title = {Acute kidney injury in liver cirrhosis: Combining microbiome and metabolome in the search for biomarkers},
journal = {Zeitschrift für Gastroenterologie},
year = {2024},
volume = {62},
number = {05},
pages = {e505--e506},
doi = {10.1055/s-0044-1786949}
}
EUVIMED